Find Academic Supervisors

David M Bannerman is Professor of Behavioural Neuroscience in the Department of Experimental Psychology at the University of Oxford and Head of the Behavioural Neuroscience Unit. His research program centers on the neurobiological mechanisms of learning, memory, and emotion, with a strong translational focus on neuropsychiatric disorders including schizophrenia, anxiety, depression, and Alzheimer's Disease, as well as the critical relationship between sleep and behavior. His academic training includes a BSc (Hons) in Psychology from the University of Bristol and a PhD in Neuroscience from the University of Edinburgh. Professor Bannerman's group employs multidisciplinary approaches to investigate neurotransmitter systems, neural plasticity, and their disruptions in brain disorders. Current work integrates molecular, circuit, and behavioral analyses using rodent models to understand how impairments in these systems lead to cognitive and emotional dysfunction, with particular emphasis on synaptic mechanisms in Alzheimer's Disease and schizophrenia models. Analysis of his 2024-2025 publications reveals dominant themes in sleep neuroscience (spindle oscillations, torpor-sleep interactions), Alzheimer's pathology (tau, amyloid-β), and psychedelic neuropharmacology. The work consistently leverages advanced rodent models and techniques to bridge molecular mechanisms with behavioral outcomes in neuropsychiatric conditions. Scientific recognition includes: William R. Miller Fellowship in Neuroscience and Experimental Psychology Governing Body Fellowship at the University of Oxford As head of the Behavioural Neuroscience Unit, Professor Bannerman directs a research program that combines electrophysiology, molecular neuroscience, and behavioral analysis to uncover fundamental mechanisms of brain function and develop translational insights for treating neurological and psychiatric disorders.

• Behavioural Neuroscience
• Learning and Memory
• Emotion
• +2 more

Seena Fazel is a Professor of Forensic Psychiatry at the University of Oxford , where she directs the Centre for Suicide Research and co-leads the Data Science theme at the Oxford Health Biomedical Research Centre . She is an Honorary Consultant Forensic Psychiatrist with Oxford Health NHS Foundation Trust and a Senior Associate at Pembroke College . Research Interests : Her work focuses on the intersections of mental health and criminal justice , including violence risk assessment , suicide prevention , and pharmacoepidemiology of psychotropic medications. Using population-based datasets from Sweden, Finland, and Denmark, she examines modifiable risk factors for violence, suicide, and recidivism, with recent studies on β-blockers, gabapentinoids, and antipsychotics . Scientific Awards and Roles : Recipient of a Wellcome Trust Senior Research Fellowship in Clinical Science NIHR Oxford Health Biomedical Research Centre funding Editorial roles at BMJ Mental Health and The Lancet Psychiatry Contributor to WHO Prison Health Handbook Public Engagement : Frequently cited in The Guardian , New York Times , and BBC , her research informs national and international policy, including evidence to UK Parliamentary Select Committees and the Khmer Rouge Tribunal .

• Forensic Psychiatry
• Risk Assessment and Stratification
• Mental Health in Prisons
• +7 more

Dr Susannah Brain is an Associate Lecturer in Clinical Medicine at St Edmund Hall, University of Oxford. She specializes in clinical neurological tutorials for medical students and contributes to biomedical research through publications in neurology and psychiatry. Education: BA MPhil (University of Cambridge) BM BCh (University of Oxford) MRCP MRCPsych Her research interests span neurology and psychiatry, focusing on conditions such as neurodegenerative diseases, mental health disorders, and psychopharmacological interventions. Key areas include Alzheimer’s disease, addiction, and autoimmune neurological disorders. Recent articles highlight her work in cognitive neuroscience, neurodegenerative diseases, and clinical neurology. Topics range from hippocampal imaging in mild cognitive impairment to psychopharmacology in addiction treatment and epidemiological studies of Guillain-Barré syndrome.

• Neurology
• Psychiatry
• Cognitive Neuroscience
• +3 more

Dr Steven Clapcote serves as a Lecturer in Pharmacology at the School of Biomedical Sciences within the Faculty of Biological Sciences, University of Leeds, a position he has held since 2008. His academic work bridges neuropharmacology research with comprehensive teaching across biomedical sciences programs. His educational background includes: BSc, Wales MSc, Edinburgh PhD, University of Liverpool Postdoctoral training was completed at the University of Oxford (1998-2002), Mount Sinai Hospital Toronto (2002-2007), and the University of Edinburgh (2007-2008). His research focuses on identifying novel drug targets for chronic CNS diseases through human genomics and animal model validation, with expertise spanning behavioural pharmacology, brain biochemistry, and disease-associated mutation analysis. He is an active member of the Neuroscience and Behaviour research group and holds professional memberships in the British Association of Psychopharmacology (BAP) and British Neuroscience Association (BNA). As an educator, Dr Clapcote manages Neuropharmacology (BMSC2223) and Practical Research Skills (BMSC3398) modules while teaching across 15+ undergraduate courses including Medical Pharmacology, Molecular Neuroscience, and Inherited Disorders. His instructional scope covers biomedical sciences, medical sciences, human physiology, and dentistry programs, emphasizing the biological basis and treatment of neurological conditions.

• Genomics
• Animal models of brain disorders
• Brain biochemistry
• +1 more

Francesca Panin is a Senior Lecturer in the Faculty of Science and Engineering at Anglia Ruskin University (ARU), specializing in the Life Sciences department. A registered pharmacist with the GPhC, she holds a PhD in Neuroscience from the University of Sassari, Italy, and has extensive international research experience including postdoctoral work at INSERM in Bordeaux, France, and clinical research at Cambridge University Hospital. Her educational background includes a postgraduate degree in Pharmaceutical Chemistry and Technology from the University of Sassari, pharmacist qualification from the Italian Ministry of Health, and a Certificate of aptitude to work as Clinical Research Assistant from ISVM Bordeaux. She also completed a PGcert in Learning and Teaching in Higher Education at ARU and earned Fellowship of the Higher Education Academy. Dr. Panin's research interests span Neuroscience, Pharmacology, Drug Addiction, Cognitive Neuroscience, Sleep, and Electrophysiology , with specific focus on neural mechanisms underlying depression-to-mania transitions in bipolar patients, drug addiction development, new therapies for cardiac failures, polysomnography applications, and EEG-based gait activity studies. Her publication record demonstrates consistent contributions to sleep medicine, neuropharmacology, and Huntington's disease research, with recent work emphasizing hospital sleep environments and substance use disorders. Her scientific recognition includes the Fellowship of Higher Education Academy, JBI training in systematic review, and the 'Giovani Ricercatori' fellowship. She has successfully secured multiple research grants including projects on genetic polymorphisms in sleep disorders (as PI, 2022), training the ageing brain (as Co-I, 2022), and adolescent nicotine exposure (as Co-I, 2020). Dr. Panin actively supervises doctoral students including a professional doctorate candidate in Health and Social Care, Pharmacy postgraduate students, and serves as second supervisor for a PhD student researching drug addiction mechanisms. She is a member of both the Behavioural Ecology Research Group and the Biomedical Research Group at ARU, where she teaches Biomedical Science courses focusing on Physiology of Organ Systems and Pharmacology and Translational Medicine. Fluent in Italian, French, and English, she maintains an active research program bridging clinical practice and academic inquiry.

• Neuroscience
• Pharmacology
• Drug Addiction
• +5 more

Professor Richard Morriss is Professor of Psychiatry and Community Mental Health at the University of Nottingham's Faculty of Medicine & Health Sciences. He serves as the Mental Health & Technology Theme Lead for the NIHR Nottingham Biomedical Research Centre, a partnership between Nottingham University Hospitals NHS Trust and the University of Nottingham. His work focuses on bridging mental health research with technological innovations. Professor Morriss's research spans multiple areas within mental health, with particular emphasis on bipolar disorder, depression, and the application of psychological interventions. His work often explores the intersection of mental health with technology, examining how digital tools can enhance treatment delivery and monitoring. He has conducted extensive research on relapse prevention strategies, particularly for bipolar disorder, and has investigated the effectiveness of cognitive behavioral therapy approaches for various mental health conditions. His recent publications demonstrate a strong focus on evidence-based approaches to mental health treatment, with numerous studies examining the effectiveness of psychological interventions for bipolar disorder, depression, and related conditions. His work frequently employs robust methodologies including randomized controlled trials, systematic reviews, and meta-analyses. A significant portion of his research addresses implementation challenges in mental health care, particularly how to translate evidence-based practices into real-world clinical settings. As Theme Lead for Mental Health & Technology, Professor Morriss oversees a research program that explores innovative ways to deliver mental health services using digital platforms. His team investigates web-based interventions, remote monitoring, and other technology-driven approaches to improve accessibility and effectiveness of mental health care.

• Mental Health
• Bipolar Disorder
• Depression
• +5 more

Dr David Dickens is a Lecturer and Principal Investigator in the Department of Pharmacology and Therapeutics at the University of Liverpool. His research focuses on blood-brain barrier (BBB) transporters and drug delivery mechanisms for CNS treatments. His work investigates transporter pharmacology at the BBB interface, molecular properties of transport mechanisms, and pharmacogenetic approaches for personalized medicine. Current projects utilize iPSC-derived human cell models to study disease-specific BBB effects in brain cancer and inter-patient drug response variability. Recent publications (2023-2025) emphasize BBB transporter biology, particularly LAT1 and P-glycoprotein roles in CNS drug delivery for neurological disorders, with significant focus on AV-101 and clozapine transport mechanisms. Research funding includes: 2024-25 Bench Fees for Yahya Mohammed A Alzahrani (Royal Embassy of Saudi Arabia) 2017-2023 AV-101 transporter study (VistaGen Therapeutics) 2018-2021 Bench Fees for Wedad Alhassan K Mawkili (Royal Embassy of Saudi Arabia) 2017-2018 Crystallographic detector development (BBSRC) 2010-2014 Antiepileptic drug transport study (Epilepsy Research Institute) The Dickens Lab pioneers advanced iPSC-based BBB models for transporter research, collaborating internationally as demonstrated by the 2025 Lancet Neurology review on BBB therapeutic strategies.

• Blood-Brain Barrier Biology
• Drug Transporter Pharmacology
• Molecular Properties of Transporters
• +3 more

Dr Eun-Mee Kim serves as Lecturer in Neurobiology within the School of Psychology at Ulster University's Faculty of Life & Health Sciences. She holds multiple administrative roles including Chair of the School Ethics Committee and Project Co-Ordinator for the Masters degree Conversion Course. Her academic journey includes an M.Sc. from Seoul National University and Ph.D. from the University of Minnesota. Dr. Kim's research centers on neurodegenerative disease mechanisms with dual focus areas: (1) Alzheimer's and Parkinson's disease neurobiology examining oligomer-induced behavioral decline and nanoparticle effects on protein misfolding; (2) Brain reward circuitry investigating opioid roles in ingestive behavior and melanocortin-neuropeptide interactions in feeding regulation. Her work bridges molecular neuroscience with behavioral outcomes using rodent models. Her research program has secured funding from prestigious sources including the Wellcome Trust, European Commission, and industry partners like Senexis Ltd. The 2009-2012 European Commission project 'Do nanoparticles induce neurodegenerative diseases?' specifically investigated reactive oxidative species formation and protein aggregation phenomena. As an educator, Dr. Kim coordinates final-year modules in Psychopharmacology and Behavioural Neuroscience while supervising PhD students. She maintains professional affiliations as a Fellow of the Higher Education Academy and Member of Alzheimer's Research UK, demonstrating commitment to both academic excellence and disease-focused research communities.

• Neurobiology of Alzheimer's Disease
• Neurobiology of Parkinson's Disease
• Brain Reward Mechanisms
• +4 more

Dr. Adam Todd is a Professor in the Department of Pharmacy within the School of Pharmacy and Life Sciences at the University of Sunderland. With a doctoral thesis completed in 2009 on 'The Role and Inhibition of Reactive Oxygen Species (ROS) in Psoriasis,' he has established a robust research career spanning over 15 years in pharmaceutical sciences, with a growing focus on oncology pharmacy and healthcare disparities. His academic journey shows progression from fundamental pharmaceutical research to sophisticated healthcare system investigations. His doctoral work focused on psoriasis mechanisms, while his subsequent research expanded into cancer pharmacotherapy, community pharmacy practice, and healthcare disparities. Dr. Todd's research interests center on critical issues at the intersection of pharmacy practice and cancer care. His work examines socio-demographic disparities in cancer treatment access, the role of community pharmacists in early cancer detection, appropriate medication use in palliative care settings, and pharmaceutical education. Recent publications demonstrate a sophisticated approach to investigating healthcare inequalities through population-based studies, qualitative interviews, and systematic reviews. Analysis of his recent publications (2020-2024) reveals a strong focus on healthcare disparities in cancer treatment, particularly examining how socioeconomic factors influence access to biomarker-guided therapies for breast cancer and non-small cell lung cancer. His work also continues to explore community pharmacy's potential role in early cancer identification, with multiple studies on head and neck cancer detection. 4 publications in 2023-2024 alone Multiple studies in high-impact journals including Cancer Epidemiology, Biomarkers & Prevention Research cited in healthcare policy discussions on cancer care equity Dr. Todd maintains active collaborations with researchers across the University of Sunderland and the UK healthcare system. His work bridges academic research with practical applications in pharmacy practice and patient care, making significant contributions to both scholarly knowledge and real-world healthcare delivery.

• Oncology Pharmacy
• Cancer Treatment Disparities
• Community Pharmacy Practice
• +6 more

Dr. Adam Barrett is an Associate Professor in Machine Learning and Data Science within the School of Engineering and Informatics at the University of Sussex. His interdisciplinary research spans complexity science, neuroscience of consciousness, and sustainability applications across multiple domains. His educational background includes: PhD in Theoretical Physics from the University of Oxford (Balliol College), focusing on string theory Mathematical Tripos (Parts I, II, III) at St John's College, Cambridge Dr. Barrett's research program is built around developing and applying complexity science and data science tools to fundamental questions across disciplines. His primary focus is on neuroscience of consciousness, where he develops mathematical frameworks for measuring complexity, emergence, and information integration, applying these to brain imaging data from various states including wakeful rest, anesthesia, sleep, and psychedelic states. He also applies complexity metrics to ecological systems through ecoacoustics research and explores stability in post-growth economies using Minskyan models. His environmental work includes time series analysis and machine learning applications for drought forecasting using satellite imaging data. Analysis of Dr. Barrett's recent publications reveals a cohesive research trajectory centered on information theory and complexity metrics, with applications spanning neuroscience, ecology, and environmental science. His work demonstrates strong theoretical development alongside practical applications, with several papers receiving significant citations in the consciousness and complexity science communities. His research has been supported by multiple grants including: 'Listening Below: Investigating Complexity Metrics for Ecoacoustics in Reef and Soil Ecosystems' (NERC, 2023) 'Toward a Measure of Soundscape Dynamical Acoustic Complexity using Causal Analysis and AI' (EPSRC, 2022-2023) 'Explaining Consciousness as Neural Dynamical Complexity' (EPSRC, 2013-2018) Dr. Barrett actively contributes to academic training at Sussex as Convenor for the 'Algorithmic Data Science' (MSc) and 'Fundamentals of Machine Learning' (2nd year) modules. His research group maintains interdisciplinary collaborations across neuroscience, ecology, economics, and environmental science, reflecting the cross-cutting nature of complexity science approaches.

• Machine Learning
• Data Science
• Complexity Science
• +5 more

Dr. Jackie Knight serves as Senior Lecturer in Medical Education at Brighton and Sussex Medical School (University of Brighton), where she directs NHS England-funded multi-professional simulation and fellowship programmes. Her expertise spans medical education, mental health practice, organizational development, and digital learning innovation across healthcare systems. Her educational background includes: PhD in developing change management theoretical frameworks through reflection (mental health perspective) MSc in Education MSc in Healthcare Leadership and Management BSc (Hons) in Health Studies Dr. Knight's research centers on transformative practice models that bridge professional learning, reflective practice, and organizational change. She pioneers simulation-based pedagogy and digital learning hubs to enhance interprofessional collaboration, with recent work scaling family-integrated care models and VR applications for foundation programmes. Her scholarship emphasizes practical implementation within NHS constraints while fostering sustainable workforce development. Analysis of her 2019-2023 publications reveals three dominant trajectories: (1) Digital innovation in medical education (33%), particularly VR simulation and learning hubs; (2) Mental health systems transformation (33%), focusing on threshold concepts and antipsychotic safety; (3) Interprofessional practice scaling (33%), including family-integrated care and communication frameworks. These intersect at the nexus of education theory and clinical implementation. Her recognitions include: Senior Fellowship of the Higher Education Academy (SFHEA) 2023 Canterbury Christchurch University Poster Prize for Cancer Pharmacy Digital Hub As an active supervisor, Dr. Knight provides dissertation guidance at Master's and PhD levels while leading £1.2M+ in active grants. Her NHS England and HEE-funded projects support 75+ healthcare professionals annually through simulation fellowships and leadership development. These initiatives feature embedded research components yielding high-impact publications and service improvements. She directs the Multi-professional Simulation Fellowship programme and Steps for Success initiative, coordinating teams across 12 NHS trusts. Her groups specialize in translating educational theory into practice through co-designed simulation scenarios, digital resource development, and change management frameworks that address real-world clinical challenges in mental health and interdisciplinary care.

• Medical Education
• Mental Health and Psychiatric Practice
• Organizational Development
• +5 more

Dr. Peter West-Oram is an Associate Professor in Bioethics within the Clinical and Experimental Medicine department at Brighton and Sussex Medical School (BSMS), part of the University of Sussex. He joined BSMS in September 2017 and maintains a dual affiliation as a Visiting Research Fellow in the Emmy Noether Research Group Political Philosophy and Bioethics at Christian-Albrechts-University in Kiel, Germany, where he previously served as a Senior Research Fellow. His research focuses on the intersection of political philosophy and bioethics, particularly examining public health ethics, medical ethics, and global justice frameworks. Dr. West-Oram has developed significant expertise in solidarity-based approaches to healthcare systems, conscientious objection in medical practice, and ethical considerations in refugee and migrant health. His current work explores the notion of 'reasonableness' in healthcare provision, building on his extensive publication record in leading bioethics journals. Analysis of his recent publications reveals a consistent trajectory examining ethical frameworks for healthcare systems through lenses of solidarity, justice, and political philosophy. His work spans theoretical foundations of global health justice to practical applications in pandemic response, refugee healthcare, and conscientious objection policies. Notably, his research demonstrates increasing engagement with real-world policy implications, particularly evident in his COVID-19 ethics work and ongoing research on medical research ethics among UK doctors. Active researcher with publications in Bioethics, Public Health Ethics, and Journal of Medical Ethics Principal investigator on Institute of Medical Ethics grant (2025-2025) Regular contributor to policy discussions on healthcare ethics International collaborator across European institutions Dr. West-Oram's teaching encompasses academic skills development, ethics of organ donation, reproductive ethics, and political philosophy. He actively supervises student research projects, particularly in areas aligning with his expertise in bioethics and healthcare justice. His dual institutional affiliations enable him to bridge theoretical bioethics with practical healthcare applications across national contexts, particularly between the UK and Germany.

• Bioethics
• Political Philosophy
• Public Health Ethics
• +3 more